Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NMRA Neumora Therapeutics, Inc.

盘后交易 01-06 18:14:14 EST

2.48

+0.31

+14.29%

盘后2.44

-0.04-1.62%

18:12 EST

最高2.59	最低2.19	成交量1,264万
今开2.24	昨收2.17	日振幅18.43%
总市值4.01亿	流通市值2.11亿	总股本1.62亿
成交额3,050万	换手率14.88%	流通股本8,492万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":2.48,"timestamp":1736197200000,"preClose":2.17,"halted":0,"volume":12637369,"hourTrading":{"tag":"盘后","latestPrice":2.4397,"preClose":2.48,"latestTime":"18:12 EST","volume":106252,"amount":261913.9106764,"timestamp":1736205155152},"delay":0,"floatShares":84920162,"shares":161561064,"eps":-1.863829,"marketStatus":"盘后交易","change":0.31,"latestTime":"01-06 18:14:14 EST","open":2.24,"high":2.59,"low":2.19,"amount":30495894.804561798,"amplitude":0.184332,"askPrice":2.44,"askSize":469,"bidPrice":2.41,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.863829,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1736211600000},"marketStatusCode":4,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":2.17,"preHourTrading":{"tag":"盘前","latestPrice":2.24,"preClose":2.17,"latestTime":"09:29 EST","volume":516368,"amount":1176537.8784895998,"timestamp":1736173777558},"postHourTrading":{"tag":"盘后","latestPrice":2.4397,"preClose":2.48,"latestTime":"18:12 EST","volume":106252,"amount":261913.9106764,"timestamp":1736205155152},"volumeRatio":0.897199,"optionData":{"bulkOrders":[{"symbol":"NMRA","call":false,"expireDate":1740114000000,"strike":"2.5","timestamp":1736178751731,"price":0.5,"volume":2059,"amount":102950,"type":"-"},{"symbol":"NMRA","call":true,"expireDate":1740114000000,"strike":"2.5","timestamp":1736178751731,"price":0.4,"volume":2059,"amount":82360,"type":"-"}]},"impliedVol":8.2927,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/NMRA","defaultTab":"news","newsList":[{"id":"2501253945","title":"Neumora Therapeutics, Inc.盘中异动 急速拉升6.91%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501253945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501253945?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:35","pubTimestamp":1736174115,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时35分，Neumora Therapeutics, Inc.股票出现波动，股价急速上涨6.91%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223515a2179737&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223515a2179737&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NMRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2501388082","title":"B of A Securities：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501388082","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501388082?lang=zh_cn&edition=full","pubTime":"2025-01-06 19:51","pubTimestamp":1736164291,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至7.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/06195147168585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2500111002","title":"Neumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500111002?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914719,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.股票出现波动，股价大幅上涨12.57%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","NMRA"],"gpt_icon":0},{"id":"1123859302","title":"医药股Neumora重磅失利！抗忧郁疗法临床试验未达标，股价暴跌引市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1123859302","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123859302?lang=zh_cn&edition=full","pubTime":"2025-01-03 08:34","pubTimestamp":1735864446,"startTime":"0","endTime":"0","summary":"$Neumora Therapeutics, Inc.$ 的主要抗忧郁药物navacaprant在第三期KOASTAL-1研究中未能达成预期目标，导致股价周四大跌81.42%。Neumora Therapeutics于周四宣布，其针对主要忧郁症的Phase 3 KOASTAL-1临床试验结果不尽如人意，未能达成主要终点。然而，最新的试验资料显示，这款药物并未有效改善受试者的病情，令市场信心受到重创。根据分析师的评估，此次失败可能会影响Neumora未来的研发计划与资金运作。未来，Neumora需要重新评估其产品线及策略，以应对当前困境，并寻找其他潜在的成功路径。","market":"us","thumbnail":"https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dbac0cf213b09ef74652dbc011c623d5","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"医药股Neumora重磅失利！抗忧郁疗法临床试验未达标，股价暴跌引市场关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"gpt_icon":1},{"id":"2500082379","title":"BUZZ--美国股票走势-特斯拉、铜矿商、天然气公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2500082379","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500082379?lang=zh_cn&edition=full","pubTime":"2025-01-03 02:47","pubTimestamp":1735843620,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.62%，报42286.94点；标普500指数.SPX下跌0.61%，报5846.53点；纳斯达克综合指数.IXIC下跌0.71%，报19173.25点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** Vistra Corp VST.N，上涨 5.7. ** Freeport-McMoRan Inc FCX.N： ** Ero Copper Corp ERO.N： ** Hudbay Minerals Inc HBM.N：BUZZ - 尽管需求预测疲软，铜矿商仍然上涨 nL4N3NB0TZ. ** Williams Companies Inc WMB.N:BUZZ - 天然气公司因液化天然气出口增加和天气转冷而上涨 nL4N3NY0SN  标普 500 指数的 11 个主要行业： 指数 RIC指数名称百分比变化<.SPX标准普尔 500 指数-0.61 <.SP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nL4T3NY0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXT","LMT","LU1145028129.USD","LU0053666078.USD","BIIB","CUBE","VICI","WMB","CNX","DVN","IE00BN8TJ469.HKD","SG9999002232.USD","LU0788108826.HKD","LU1150488218.USD","NEM","LHX","LU0417517546.SGD","CRVS","HAL","SLB","LU2347655156.SGD","SYNA","FCX","TSLA","PBF","LU0612318385.USD","TSYW.SI","LU0466842654.USD","LU0985489474.SGD","LU1992135399.USD","LNG","LU0170899867.USD","LU0077335932.USD","NMRA","BK4574","CVX","BK4015","LU1582987324.SGD","SG9999015986.USD","XOM","SCCO","LU1223082519.USD","MODG","USB","LU0742534661.SGD","CVNA","CEG"],"gpt_icon":1},{"id":"2500973753","title":"BUZZ--美国股票走势-特斯拉、波音、黄金矿工","url":"https://stock-news.laohu8.com/highlight/detail?id=2500973753","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500973753?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:47","pubTimestamp":1735832824,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI上涨0.24%，报42,645.27点。标普500指数.SPX上涨0.33%，报5901.00点；纳斯达克综合指数.IXIC上涨0.38%，报19383.52点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** First Solar Inc FSLR.OQ，涨幅 4.3. ** Shineco Inc SISI.OQ，下跌 33.1% ** SoFi Technologies Inc SOFI.O：BUZZ - 在KBW将其评级下调至 \"underpeform \"后下跌 nL4N3NY0DZ  ** Biogen Inc BIIB.O：BUZZ--Piper Sandler下调Biogen评级，称该公司正处于转型期。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b45e79482db500e5541b1bf6d5191f4d","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nL4S3NY0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","LU1989764664.SGD","LU1914381329.SGD","LU2237443978.SGD","MACW.SI","SLB","LU0498741114.HKD","LMT","LU1066053197.SGD","FSLR","CGBS","LHX","BIIB","BFLY","LU2326559502.SGD","AMAT","EVTL","IE00BWXC8680.SGD","TSYW.SI","VICI","LU0528227936.USD","TSLA","NMRA","BA","LU1153585028.USD","CEG","NEM","CTCX","AU","LU0823411888.USD","LICY","LU0368265418.SGD","LU2756315318.SGD","USB","ENPH","LU0072462426.USD","LU0124384867.USD","CRVS","LU0158827948.USD","AAPL","HAL","FUL","BK4548","LU1989772923.USD","SISI","MODG"],"gpt_icon":1},{"id":"2500109973","title":"BUZZ-Neumora 因抑郁症药物在后期研究中失败而创下历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2500109973","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500109973?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:42","pubTimestamp":1735832543,"startTime":"0","endTime":"0","summary":"1月2日 -  ** 药物开发商Neumora TherapeuticsNMRA.O股价下跌80%至2.08美元，创下自纳斯达克上市以来的最低水平。** 经纪公司 Needham 称，数据 \"降低了 \"该药物在另外两项后期研究中取得成功的 \"可能性。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nL4S3NY0OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"gpt_icon":0},{"id":"2500992772","title":"Neumora Therapeutics, Inc.盘中异动 早盘急速下挫82.22%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500992772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500992772?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:31","pubTimestamp":1735828285,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时31分，Neumora Therapeutics, Inc.股票出现波动，股价大幅跳水82.22%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223125ab9bf5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223125ab9bf5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","NMRA"],"gpt_icon":0},{"id":"2500924426","title":"BUZZ--美国股票走势-特斯拉、金矿企业、VICI Properties","url":"https://stock-news.laohu8.com/highlight/detail?id=2500924426","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500924426?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:25","pubTimestamp":1735827923,"startTime":"0","endTime":"0","summary":".N ** SoFi Technologies Inc SOFI.O:BUZZ - 在KBW将其评级下调为 \"underpeform \"后下跌 nL4N3NY0DZ  ** Biogen Inc BIIB.O:BUZZ - Piper Sandler 下调 Biogen 的评级，称该公司正处于转型期。nL4N3NY0CC  ** VICI Properties Inc VICI.N:BUZZ--在Wedbush上调评级后上涨 nL4N3NY0GB  ** Corvus Pharmaceuticals Inc CRVS.O:BUZZ - H.C. Wainwright开始对Corvus Pharmaceuticals进行评级，给予 \"买入 \"评级。nL4N3NY0I0  ** 哈里伯顿公司 HAL.N： ** 斯伦贝谢公司SLB.N：BUZZ - 全球油田支出放缓，摩根大通下调斯伦贝谢公司和哈里伯顿公司的目标价。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nL4S3NY0LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","CRVS","NMRA","IE00BLSP4239.USD","NEM","LU2326559502.SGD","LU0498741890.SGD","BK4084","IE00BSNM7G36.USD","IE0034235303.USD","SLB","LU2756315664.SGD","IE00B1BXHZ80.USD","LU1629891620.HKD","TSLA","AU","LU1670627923.USD","LU0466842654.USD","LU1852331112.SGD","VICI","LU1032466523.USD","LMT","LU0075056555.USD","IE00BK4W5L77.USD","LU0788108826.HKD","LU2237443549.SGD","LU0654597011.USD","TSYW.SI","BK4179","HAL","LU0310799852.SGD","IE00BZ1G4Q59.USD","LU0971096721.USD","LU0640476718.USD","LU1145028129.USD","BIIB","LU0203347892.USD","LU1668664300.SGD","LU0149725797.USD","BK4207","BK4549","LU0683600562.USD","LU0689472784.USD","LU2552382132.HKD","BK4547","SG9999015986.USD","LU1223082519.USD","LHX"],"gpt_icon":1},{"id":"2500928071","title":"BUZZ-抑郁症药物在后期研究中失败，Neumora跌幅超过80","url":"https://stock-news.laohu8.com/highlight/detail?id=2500928071","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500928071?lang=zh_cn&edition=full","pubTime":"2025-01-02 20:39","pubTimestamp":1735821553,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月2日 - ** 药物开发商Neumora Therapeutics  股价下跌82%，至1.95美元** NMRA称其抑郁症实验药物navacaprant在一项后期试验中没有达到 (link)。** 该药物没有减轻抑郁症状，根据疾病严重程度量表测量，该量表可追踪悲伤、睡眠减少和悲观的想法** NMRA称，该药物在一个关键的次要目标上也没有显示出统计学意义上的显著改善 ** 该公司称，截至第三季度末，其现金余额为 3.42 亿美元，将为 2026 年中期的运营提供资金支持** 2024 年的 NMRA 下降了约 38","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"BUZZ-抑郁症药物在后期研究中失败，Neumora跌幅超过80","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"gpt_icon":0},{"id":"2500409849","title":"Neumora Therapeutics公司的抑郁症药物未能达到后期研究的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2500409849","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500409849?lang=zh_cn&edition=full","pubTime":"2025-01-02 20:06","pubTimestamp":1735819593,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics公司的抑郁症药物未能达到后期研究的主要目标路透1月2日 - Neumora Therapeutics NMRA.O周四表示，其治疗抑郁症的实验性药物未能达到后期研究的主要目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nL4S3NY0HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"gpt_icon":0},{"id":"2500643685","title":"Neumora Therapeutics, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500643685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500643685?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:47","pubTimestamp":1735667236,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时47分，Neumora Therapeutics, Inc.股票出现波动，股价快速下跌5.06%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101014716a210b055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101014716a210b055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2493703382","title":"Neumora Therapeutics, Inc.盘中异动 股价大跌5.04%报10.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493703382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493703382?lang=zh_cn&edition=full","pubTime":"2024-12-24 23:19","pubTimestamp":1735053598,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日23时19分，Neumora Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。截至发稿，该股报10.56美元/股，成交量7.6946万股，换手率0.05%，振幅6.29%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224231959984d8de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224231959984d8de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","NMRA","BK4139"],"gpt_icon":0},{"id":"2484607119","title":"Neumora Therapeutics, Inc.盘中异动 急速下跌5.07%报10.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484607119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484607119?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:48","pubTimestamp":1731955681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时48分，Neumora Therapeutics, Inc.股票出现波动，股价快速下挫5.07%。截至发稿，该股报10.29美元/股，成交量41.1481万股，换手率0.25%，振幅6.73%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024802971a7418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024802971a7418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","NMRA"],"gpt_icon":0},{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXA","LU0971096721.USD","LSCC","GKOS","LU0949170772.SGD","ILMN","LU0266512127.USD","LU1489326972.SGD","LU1363072403.SGD","MAR","OMI","BEN","PTGX","CAMP","LU0149725797.USD","LU1244550221.USD","FIS","LU0320765489.SGD","BMRN","EDIT","IRON","CSTL","BWIN","SLAB","ATUS","INSP","NYT","LU","CMS","MDGL","FRPT","AMG","SM","ST","KROS","SHAK","HIMS","NMRA","RZLT","ARES","BK4106","CI","IE00BZ1G4Q59.USD","RL","EGHT","AWI","EVER"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BMRN","ST","LU1244550221.USD","FRPT","CSTL","AMG","BEN","FOXA","LU0949170772.SGD","GKOS","NMRA","SLAB","BWIN","IRON","NYT","LU0320765489.SGD","AWI","ATUS","EGHT","OMI","FIS","CMS","BK4106","SHAK","EVER","LU0149725797.USD","LU1363072403.SGD","LU","LU0266512127.USD","CI","PTGX","LSCC","MAR","EDIT","INSP","RL","LU0971096721.USD","ARES","IE00BZ1G4Q59.USD","KROS","SM","MDGL","CAMP","LU1489326972.SGD","RZLT"],"gpt_icon":1},{"id":"2481553446","title":"Neumora Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481553446?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:33","pubTimestamp":1730741616,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时33分，Neumora Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110501333798e4054c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110501333798e4054c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","NMRA","BK4139"],"gpt_icon":0},{"id":"2480083599","title":"实时市场-脑力劳动正在进行，但神经药物开发人员仍需努力","url":"https://stock-news.laohu8.com/highlight/detail?id=2480083599","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480083599?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:38","pubTimestamp":1730475534,"startTime":"0","endTime":"0","summary":"您可以通过以下网址与我们分享您的想法  脑力劳动正在进行，但神经药物开发商仍有很长的路要走Canaccord Genuity分析师周五表示，神经系统疾病方面的需求尚未得到满足，这激起了人们对正在开发的治疗抑郁症、阿尔茨海默病和痴呆症等神经系统疾病药物试验数据的期待，这些疾病影响着全球数百万患者。嘉能可补充说，尽管在理解阿尔茨海默氏症这种神经退行性疾病方面还存在挑战，但 Leqembi 和 Kisunla 的成功已经到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","LU0708995401.HKD","SQQQ","LU0097036916.USD","DOG","BMY","LU1064131342.USD","QID","LU0234570918.USD","IE00B19Z9Z06.USD","NQmain","IE00B2B36J28.USD","DXD","DDM","LU0203347892.USD","LU0795875086.SGD","IE00BFTCPJ56.SGD","QLD","BK4504","DJX",".IXIC","IE00BJJMRZ35.SGD","BK4581","BK4532",".SPX",".DJI","JNJ","LU0320765646.SGD","BIIB","IE00B42XCP33.USD","MNQmain","LU0094547139.USD","LU0096364046.USD","PSQ","LU0354030511.USD","LU0943347566.SGD","LU0203201768.USD","BK4139","UDOW","LU0456855351.SGD","LU0061475181.USD","CRVO","NMRA","SDOW","LU0417517546.SGD","LU0122379950.USD","LU1066051225.USD","IE0034235303.USD"],"gpt_icon":1},{"id":"2480066288","title":"Neumora Therapeutics, Inc.盘中异动 临近收盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066288?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:55","pubTimestamp":1730404540,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时55分，Neumora Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.00%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035540971a39ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035540971a39ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2478952275","title":"Neumora Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478952275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478952275?lang=zh_cn&edition=full","pubTime":"2024-10-26 02:02","pubTimestamp":1729879329,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日02时02分，Neumora Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026020210ab7483f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026020210ab7483f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NMRA","BK4007","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neumoratx.com","stockEarnings":[{"period":"1week","weight":-0.8085},{"period":"1month","weight":-0.7779},{"period":"3month","weight":-0.853},{"period":"6month","weight":-0.7883},{"period":"1year","weight":-0.8676},{"period":"ytd","weight":-0.7953}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neumora Therapeutics, Inc.成立于2019年11月，当时是一家特拉华州公司，名称为RBNC Therapeutics, Inc.。该公司于2021年10月更名为Neumora Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，旨在应对全球脑部疾病危机，对脑部疾病的治疗方法采取一种根本不同的方法。该公司的治疗管道规模迅速扩大，目前包括七个临床和临床前神经科学项目，针对广泛的未得到充分服务的神经精神疾病和神经退行性疾病的新的作用机制。该公司最先进的候选产品navacaprant（NMRA-140）是一种新型的每日一次口服kappa阿片受体（KOR）拮抗剂，正在开发用于治疗重度抑郁症（MDD），该公司认为，如果获得批准，这种药物有可能提供相对于标准护理的显著优势。","exchange":"NASDAQ","name":"Neumora Therapeutics, Inc.","nameEN":"Neumora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neumora Therapeutics, Inc.,NMRA,Neumora Therapeutics, Inc.股票,Neumora Therapeutics, Inc.股票老虎,Neumora Therapeutics, Inc.股票老虎国际,Neumora Therapeutics, Inc.行情,Neumora Therapeutics, Inc.股票行情,Neumora Therapeutics, Inc.股价,Neumora Therapeutics, Inc.股市,Neumora Therapeutics, Inc.股票价格,Neumora Therapeutics, Inc.股票交易,Neumora Therapeutics, Inc.股票购买,Neumora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}